Paper 13305-49
Quantitative in vivo microscopy of interstitial lung disease using deep learning and artificial intelligence-based endobronchial optical coherence tomography
28 January 2025 • 5:00 PM - 5:15 PM PST | Moscone South, Room 203 (Level 2)
Abstract
Endobronchial optical coherence tomography (EB-OCT) is a high-resolution, bronchoscope compatible imaging technique with the potential to serve as a microscopic complement to HRCT in interstitial lung disease (ILD) for early microscopic diagnosis and therapeutic response assessment. However, integration of EB-OCT into clinical settings remains challenging due to the time- and labor-intensive qualitative evaluation and/or manual segmentation of large datasets consisting of tens of thousands of images acquired from individual patients. Here, we demonstrate the feasibility of a robust, computationally-efficient EB-OCT image analysis framework using artificial intelligence (AI) with deep learning architecture for rapid, automated ILD feature segmentation and volumetric quantification.
Presenter
Massachusetts General Hospital (United States)
Sreyankar Nandy received his PhD in Biomedical Engineering from Washington University in St. Louis, with a focus on optical and photoacoustic imaging. His postdoctoral research in Dr. Lida Hariri's pulmonary optical imaging lab at Massachusetts General Hospital and Harvard Medical School focused on the development and clinical translation of high-resolution Endobronchial OCT (EB-OCT) imaging for pulmonary applications. He is currently an instructor in medicine at Harvard Medical School, where his research involves developing novel artificial intelligence and deep learning-based quantitative optical imaging biomarkers of chronic lung diseases.